Table of contents

Clinical and epidemiological research

• Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors (14 May, 2018)

  Xavier M Teitsma, Johannes W G Jacobs, Paco M J Welsing, Pascal H P de Jong, Johanna M W Hazes, Angelique E A M Weel, Attila Pethö-Schramm, Michelle E A Borm, Jacob M van Laar, Floris P J G Lafeber, Johannes W J Bijlsma
• Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study) (31 May, 2018)

  Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, Masayuki Inoo, Hitomi Kobayashi-Haraoka, Koichi Amano, Masayuki Miyata, Yohko Murakawa, Hidekara Yasuoka, Shintaro Hirata, Eiichi Tanaka, Nobuyuki Miyasaka, Hisashi Yamanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi
• Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration (5 May, 2018)

  Kim Lauper, Dan C Nordström, Karel Pavelka, Maria Victoria Hernández, Tore K Kvien, Eirik Klami Kristianslund, Maria Jose Santos, Žiga Rotar, Florenzo Iannone, Catalin Codreanu, Galina Lukina, Sara L Gale, Khaled Sarsour, Yves Luder, Delphine Sophie Courvoisier, Cem Gabay
• The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: the STARTER study (9 June, 2018)

  Georgios Filippou, Garifallia Sakellariou, Carlo Alberto Scirè, Greta Carrara, Federica Rumi, Emanuela Bellis, Antonella Adinolfi, Alberto Batticciotto, Alessandra Bortoluzzi, Giovanni Cagnotto, Marta Caprioli, Marco Canzoni, Francesco Paolo Cavatorta, Orazio De Lucia, Valentina Di Sabatino, Antonella Draghessi, Ilaria Farina, Maria Cristina Focherini, Alessandra Gabba, Marwin Gutierrez, Luca Idolazzi, Filippo Luccioli, Pierluigi Macchioni, Marco Sergio Massarotti, Claudio Mastaglio, Luana Menza, Maurizio Muratore, Simone Parisi, Valentina Picerno, Matteo Piga, Roberta Ramonda, Bernd Raffeiner, Daniela Rossi, Silvia Rossi, Paola Rossini, Crescenzio Scioscia, Carlo Venditti, Alessandro Volpe, Annamaria Iagnocco
• Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls (6 June, 2018)

  Brigitte Michelsen, Till Uhlig, Joseph Sexton, Désirée van der Heijde, Hilde Berner Hammer, Eirik Klami Kristianslund, Ada Wierød, Gunnstein Bakland, Erik Rødevand, Frode Krøll, Jon Håvard Loge, Glenn Haugeberg, Tore K Kvien
• Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study (26 June, 2018)

  Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, Joachim Sieper, Pentti Järvinen, Lai-Shan Tam, Carlo Salvarani, Tae-Hwan Kim, Alan Solinger, Yakov Datsenko, Chandrasena Pamulapati, Sudha Visvanathan, David B Hall, Stella Aslanyan, Paul Scholl, Steven J Padula
• Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study (2 June, 2018)

  Santiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, Fernando Pimentel Santos, Polina Putrik, Elena Nikiphorou, Sam Norton, Anna Molto, Maxime Dougados, Désirée van der Heijde, Robert B M Landewé, Filip E van den Bosch, Annelies Boonen
• Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (1 June, 2018)

  Uta Kiltz, Désirée van der Heijde, Annelies Boonen, Nurullah Akkoc, Wilson Bautista-Molano, Ruben Burgos-Vargas, James Cheng-Chung Wei, Praveena Chiowchanwisawakit, Maxime Dougados, M Tuncay Duruoz, Bassel Kamal Elzorkany, Inna Gaydukova, Lianne S Gensler, Michele Gilio, Simeon Grazio, Jieruo Gu, Robert D Inman, Tae-Jong Kim, Victoria Navarro-Compan, Helena Marzo-Ortega, Salih Ozgocmen, Fernando Pimentel dos Santos, Michael Schirmer, Simon Stebbings, Filip E Van den Bosch, Astrid van Tubergen, Juergen Braun
• Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis (5 May, 2018) Free

  Gabriella Moroni, Paolo Gilles Vercelloni, Silvana Quaglini, Mariele Gatto, Davide Gianfreda, Lucia Sacchi, Francesca Raffiotta, Margherita Zen, Gloria Costantini, Maria Letizia Urban, Federico Pieruzzi, Piergiorgio Messa, Augusto Vaglio, Renato Alberto Sinico, Andrea Doria
• Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model (6 June, 2018)

  Wanlong Wu, Suzana Jordan, Mike Oliver Becker, Rucsandra Dobrota, Britta Maurer, Håvard Fretheim, Shuang Ye, Elise Siegert, Yannick Allanore, Anna-Maria Hoffmann-Vold, Oliver Distler
• Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System (14 May, 2018)

  Zachary S Wallace, Rachel Wallwork, Yuqing Zhang, Na Lu, Frank Cortazar, John L Niles, Eliot Heher, John H Stone, Hyon K Choi
• Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis (3 May, 2018)

  Liang Wu, Xiao-Qian Li, Tanvi Goyal, Sean Eddy, Matthias Kretzler, Wen-Jun Ju, Min Chen, Ming-Hui Zhao